1. Signaling Pathways
  2. MAPK/ERK Pathway
  3. MAPKAPK2 (MK2)

MAPKAPK2 (MK2) 

Mitogen-activated protein kinase activated protein kinase 2; MAP kinase activated protein kinase 2; MAPK activated protein kinase 2; MAPKAP kinase 2

MAP kinase-activated protein kinase 2 (MAPKAPK2) is an enzyme that in humans is encoded by the MAPKAPK2 gene. MAPKAP kinase-2 (MK2) is originally identified by its phosphorylation of glycogen synthase at serine-7 and the corresponding serine in a peptide (GS peptide-1) modelled after the N-terminus of glycogen synthase.

MAPKAP kinase-2 is a novel protein kinase activated by mitogen-activated protein kinase. This MAP kinase activated protein kinase, termed MAPKAP kinase-2, is distinguished from S6 kinase-II (MAPKAP kinase-1) by its response to inhibitors, lack of phosphorylation of S6 peptides and amino acid sequence.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-116533
    RMM-46 Inhibitor
    RMM-46 是 MSK/RSK 家族激酶的选择性可逆共价抑制剂。
    RMM-46
  • HY-162700
    MK2-IN-6 Inhibitor
    MK2-IN-6 (Compound 11) 是一种有效的,选择性不可逆的 MK2 抑制剂,其 IC50 值为 2.3 nM。MK2-IN-6 抑制 MK2 激酶活性,实现对 MK2 信号的长时间抑制,降低巨噬细胞的病理性炎症因子。MK2-IN-6 在体外和体内均能抑制巨噬细胞的 M2 样蛋白表型,有望用于结肠癌研究。
    MK2-IN-6
目录号 产品名 / 同用名 应用 反应物种